SYRE vs. FXAIX
Compare and contrast key facts about Spyre Therapeutics Inc. (SYRE) and Fidelity 500 Index Fund (FXAIX).
FXAIX is managed by Fidelity.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SYRE or FXAIX.
Correlation
The correlation between SYRE and FXAIX is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SYRE vs. FXAIX - Performance Comparison
Key characteristics
SYRE:
-0.16
FXAIX:
1.81
SYRE:
0.27
FXAIX:
2.44
SYRE:
1.03
FXAIX:
1.33
SYRE:
-0.12
FXAIX:
2.76
SYRE:
-0.33
FXAIX:
11.43
SYRE:
34.28%
FXAIX:
2.04%
SYRE:
71.34%
FXAIX:
12.86%
SYRE:
-99.12%
FXAIX:
-33.79%
SYRE:
-92.44%
FXAIX:
-1.48%
Returns By Period
In the year-to-date period, SYRE achieves a -2.71% return, which is significantly lower than FXAIX's 2.55% return.
SYRE
-2.71%
-5.70%
-8.67%
-4.39%
-35.10%
N/A
FXAIX
2.55%
1.89%
13.50%
22.21%
14.42%
13.15%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SYRE vs. FXAIX — Risk-Adjusted Performance Rank
SYRE
FXAIX
SYRE vs. FXAIX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Spyre Therapeutics Inc. (SYRE) and Fidelity 500 Index Fund (FXAIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SYRE vs. FXAIX - Dividend Comparison
SYRE has not paid dividends to shareholders, while FXAIX's dividend yield for the trailing twelve months is around 1.21%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SYRE Spyre Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FXAIX Fidelity 500 Index Fund | 1.21% | 1.25% | 1.45% | 1.69% | 1.22% | 1.60% | 1.95% | 2.07% | 1.81% | 2.01% | 2.56% | 2.63% |
Drawdowns
SYRE vs. FXAIX - Drawdown Comparison
The maximum SYRE drawdown since its inception was -99.12%, which is greater than FXAIX's maximum drawdown of -33.79%. Use the drawdown chart below to compare losses from any high point for SYRE and FXAIX. For additional features, visit the drawdowns tool.
Volatility
SYRE vs. FXAIX - Volatility Comparison
Spyre Therapeutics Inc. (SYRE) has a higher volatility of 16.90% compared to Fidelity 500 Index Fund (FXAIX) at 3.85%. This indicates that SYRE's price experiences larger fluctuations and is considered to be riskier than FXAIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.